dc.contributor.author
Katzmann, Julius L.
dc.contributor.author
Mahfoud, Felix
dc.contributor.author
Böhm, Michael
dc.contributor.author
Schulz, Martin
dc.contributor.author
Laufs, Ulrich
dc.date.accessioned
2019-05-24T06:15:51Z
dc.date.available
2019-05-24T06:15:51Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/24638
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-2401
dc.description.abstract
Background: Many patients at high cardiovascular risk do not reach targets for low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP). Depression is a frequent comorbidity in these patients and contributes to poor medication adherence.
Objective: The aim of this study was to elucidate the associations between adherence to lipid- and BP-lowering drugs, the diagnosis of depression, and the control of LDL-C and BP.
Patients and methods: This study was conducted as multicenter, single-visit cross-sectional study in Germany. Adherence was assessed by the Morisky Medication Adherence Scale-8 (MMAS-8), and depression was assessed as documented in the patient chart.
Results: A total of 3,188 ambulatory patients with hypercholesterolemia (39.8%), stable coronary artery disease (CAD; 7.4%), or both (52.9%) were included. Patients had a history of myocardial infarction (30.8%), diabetes (42.0%), were smokers (19.7%), and 16.1% had the investigator-reported diagnosis of depression. High or moderate adherence to lipid-lowering medication compared to low adherence was associated with lower LDL-C levels (105.5±38.3 vs 120.8±42.4 mg/dL) and lower BP (systolic BP 133.4±14.5 vs 137.9±13.9 mmHg, diastolic BP 78.3±9.6 vs 81.8±9.6 mmHg) and with a higher proportion of patients achieving the guideline-recommended LDL-C (16.9% vs 10.1%) and BP target (52.2% vs 40.8%, all comparisons P<0.0001). Adherence was worse in patients with depression. Correspondingly, patients with depression showed higher LDL-C levels, higher BP, and a lower probability of achieving the LDL-C and BP goal. Medication adherence correlated between BP- and lipid-lowering medications.
Conclusion: Self-reported medication adherence can be easily obtained in daily practice. A low adherence and the diagnosis of depression identify patients at risk for uncontrolled LDL-C and BP who likely benefit from intensified care.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc/4.0/
dc.subject
blood pressure
en
dc.subject
cardiovascular disease
en
dc.subject
coronary artery disease
en
dc.subject
LDL cholesterol
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::615 Pharmakologie, Therapeutik
dc.title
Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.2147/PPA.S182765
dcterms.bibliographicCitation.journaltitle
Patient Preference and Adherence
dcterms.bibliographicCitation.pagestart
9
dcterms.bibliographicCitation.pageend
19
dcterms.bibliographicCitation.volume
13
dcterms.bibliographicCitation.url
https://doi.org/10.2147/PPA.S182765
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Pharmazie
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.issn
1177-889X (Print)